Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis-Reference-Cited by-同舟云学术

Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis

Published:2009-08-15 Issue:4 Volume:180 Page:371-376
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Williams Kathy N.,Brickner Steven J.,Stover Charles K.,Zhu Tong,Ogden Adam,Tasneen Rokeya,Tyagi Sandeep,Grosset Jacques H.,Nuermberger Eric L.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference33 articles.

1. Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis.Clin Chest Med1980;1:231–241.

2. Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis.Int J Tuberc Lung Dis2000;4:796–806.

3. Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

4. Park SK, Kim CT, Song SD. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.Int J Tuberc Lung Dis1998;2:877–884.

5. Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing Regimens

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic DNA Vaccine TargetingMycobacterium tuberculosisPersisters Shortens Curative Tuberculosis Treatment;2024-09-07

2. Synthesis and Antibacterial Activities of Linezolid Analogues with C₅‐thioether/N,S‐acetal Amide;ChemistrySelect;2024-08-06

3. New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?;Pharmaceutics;2024-06-17

4. Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities;European Journal of Medicinal Chemistry;2024-04

5. Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2024-02-07